MMAFintermediate 1 is a key synthetic precursor to the tubulin polymerization inhibitor MMAF, a potent cytotoxin employed in antibody-drug conjugates (ADCs). Its role is critical for producing payloads used in ADC research and development, including applications in both in vitro cytotoxicity assays and in vivo preclinical studies of targeted cancer therapies.